Tauropharm

TauroPharm GmbH is a German company founded in 2000, specializing in antimicrobial solutions aimed at enhancing patient safety. The company offers an innovative product portfolio, including TauroLock™ for venous vascular access devices and TauroPace™ for cardiac implantable electronic devices. These solutions are designed to prevent infections and improve the safety and efficacy of medical procedures.

Committed to the principle that “prevention is always better than cure,” TauroPharm focuses on reducing infection-related complications in areas such as dialysis, oncology, parenteral nutrition, and rhythm surgery. 

By preventing complications, the company not only improves patient outcomes but also helps minimize healthcare costs.

The TauroLock™ range is specifically tailored for use with central venous catheters and port systems, leveraging a unique combination of taurolidine and other active ingredients to provide robust antimicrobial protection. 

As TauroPharm continues to grow its international presence, it remains dedicated to advancing awareness and solutions for infection prevention in diverse medical fields.

Website – https://www.tauropharm.com/